TNGX icon

Tango Therapeutics
TNGX

Overview Fund Activity

31 hedge funds and large institutions have $150M invested in Tango Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 9 closing their positions.

Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
5
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCA
1
Southpoint Capital Advisors
New York
$22.8M
2
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$10.5M
3
FCM
3
Farallon Capital Management
California
$3.41M
4
PVI
4
Pura Vida Investments
New York
$1.13M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$159K

Top Sellers

1
BI
1
BVF Inc
California
$0
2
VA
2
VR Adviser
New York
$0
3
IC
3
Ikarian Capital
Texas
$0
4
NCM
4
Nantahala Capital Management
Connecticut
$0
5
ACM
5
Altium Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$437K -$475K -41,776 -52%
AW
27
Alaethes Wealth
Nevada
$228K – – –
HF
28
HRT Financial
New York
$167K +$8.31K +733 +5%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$159K +$159K +14,009 New
OWP
30
Old Well Partners
North Carolina
$131K +$131K +11,554 New
UBS Group
31
UBS Group
Switzerland
$37K +$5.22K +460 +16%
BI
32
BVF Inc
California
– -$8.9M -800,000 Closed
VA
33
VR Adviser
New York
– -$5.56M -500,000 Closed
IC
34
Ikarian Capital
Texas
– -$3.34M -300,250 Closed
NCM
35
Nantahala Capital Management
Connecticut
– -$1.96M -175,915 Closed
ACM
36
Altium Capital Management
New York
– -$1.33M -120,000 Closed
HM
37
HealthCor Management
New York
– -$456K -41,032 Closed
BFM
38
Boothbay Fund Management
New York
– -$375K -33,713 Closed
PAM
39
Panagora Asset Management
Massachusetts
– -$52K -4,660 Closed
1
2